QLGN - Qualigen Therapeutics GAAP EPS of -$0.61 revenue of $5.65M April, 01 2022 09:00 AM Qualigen Therapeutics Inc. Qualigen Therapeutics press release (NASDAQ:QLGN): FY GAAP EPS of -$0.61. Revenue of $5.65M (+98.2% Y/Y). Shares -3.92% PM. For further details see: Qualigen Therapeutics GAAP EPS of -$0.61, revenue of $5.65M